ADAGENE INC-ADR
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About ADAG
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. The Company is principally engaged in the research, development and production of monoclonal antibody drugs for cancers. The Company’s main products include: ADG106 is being developed for the treatment of advanced solid tumors and non-Hodgkin's lymphoma, or NHL. ADG126 is designed to address the toxicity and efficacy issues related to the MOA of existing approved CTLA-4 immuno-oncology therapies and to expand the potential of CTLA-4 as a target for the treatment of cancer. ADG116 is designed to target a unique conserved epitope of CTLA-4. And ADG104, a monospecific antibody that targets PD-L1 and is in Phase Ib and Phase II clinical trials concurrently in China.
Find out what a historical investment in ADAGENE INC-ADR would be worth today using our ADAG stock calculator.
$89.51M
-
0.00%
3.29K
$2.00
$1.90
$2.00
$3.58
$1.33
Ready to start your investing journey with Stake?
Open an accountADAG FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ADAG
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ADAG
on Stake
Buy ADAG from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of ADAG from only US$10 with fractional shares
